Abacept treatment for patients with early active primary Sjögren's syndrome: OPEN-LABEL EXTENSION PHASE OF A RANDOMIZED CONTROLLED PHASE III TRIAL

S. Arends; J. F. Van Nimwegen; E. Mossel; G. S. Van Zuiden; K. Delli; A. J. Stel; B. Van der Vegt; E. A. Haacke; L. Olie; L. Los; G. M. Verstappen; S. A. Pringle; F. K. L. Spijkervet; F. G. M. Kroese; A. Vissink; H. Bootsma

doi:10.1136/annrheumdis-2020-eular.4439

Abacept treatment for patients with early active primary Sjögren's syndrome: OPEN-LABEL EXTENSION PHASE OF A RANDOMIZED CONTROLLED PHASE III TRIAL

S. Arends, J. F. Van Nimwegen, E. Mossel, G. S. Van Zuiden, K. Delli, A. J. Stel, B. Van der Vegt, E. A. Haacke, L. Olie, L. Los, G. M. Verstappen, S. A. Pringle, F. K. L. Spijkervet, F. G. M. Kroese, A. Vissink, H. Bootsma

Translational Immunology Groningen (TRIGR)

Onderzoeksoutput › Academic

Originele taal-2	English
Pagina's (van-tot)	102-102
Aantal pagina's	1
Tijdschrift	Annals of the Rheumatic Diseases
Volume	79
DOI's	https://doi.org/10.1136/annrheumdis-2020-eular.4439
Status	Published - jun.-2020
Evenement	Annual European Congress of Rheumatology (EULAR) - Duur: 3-jun.-2020 → …

Toegang tot document

10.1136/annrheumdis-2020-eular.4439

https://ard.bmj.com/content/79/Suppl_1/102.2

Handle.net

Permanente koppeling

Citeer dit

Arends, S., Van Nimwegen, J. F., Mossel, E., Van Zuiden, G. S., Delli, K., Stel, A. J., Van der Vegt, B., Haacke, E. A., Olie, L., Los, L., Verstappen, G. M., Pringle, S. A., Spijkervet, F. K. L., Kroese, F. G. M., Vissink, A., & Bootsma, H. (2020). Abacept treatment for patients with early active primary Sjögren's syndrome: OPEN-LABEL EXTENSION PHASE OF A RANDOMIZED CONTROLLED PHASE III TRIAL. Annals of the Rheumatic Diseases, 79, 102-102. https://doi.org/10.1136/annrheumdis-2020-eular.4439

@article{02ecca9e1297442ea7d1918cb9968214,

title = "Abacept treatment for patients with early active primary Sj{\"o}gren's syndrome: OPEN-LABEL EXTENSION PHASE OF A RANDOMIZED CONTROLLED PHASE III TRIAL",

author = "S. Arends and {Van Nimwegen}, {J. F.} and E. Mossel and {Van Zuiden}, {G. S.} and K. Delli and Stel, {A. J.} and {Van der Vegt}, B. and Haacke, {E. A.} and L. Olie and L. Los and Verstappen, {G. M.} and Pringle, {S. A.} and Spijkervet, {F. K. L.} and Kroese, {F. G. M.} and A. Vissink and H. Bootsma",

year = "2020",

month = jun,

doi = "10.1136/annrheumdis-2020-eular.4439",

language = "English",

volume = "79",

pages = "102--102",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

note = "Annual European Congress of Rheumatology (EULAR) ; Conference date: 03-06-2020",

}

Arends, S, Van Nimwegen, JF, Mossel, E, Van Zuiden, GS , Delli, K , Stel, AJ , Van der Vegt, B, Haacke, EA, Olie, L, Los, L , Verstappen, GM , Pringle, SA , Spijkervet, FKL , Kroese, FGM , Vissink, A & Bootsma, H 2020, 'Abacept treatment for patients with early active primary Sjögren's syndrome: OPEN-LABEL EXTENSION PHASE OF A RANDOMIZED CONTROLLED PHASE III TRIAL', Annals of the Rheumatic Diseases, vol. 79, blz. 102-102. https://doi.org/10.1136/annrheumdis-2020-eular.4439

TY - JOUR

T1 - Abacept treatment for patients with early active primary Sjögren's syndrome

T2 - Annual European Congress of Rheumatology (EULAR)

AU - Arends, S.

AU - Van Nimwegen, J. F.

AU - Mossel, E.

AU - Van Zuiden, G. S.

AU - Delli, K.

AU - Stel, A. J.

AU - Van der Vegt, B.

AU - Haacke, E. A.

AU - Olie, L.

AU - Los, L.

AU - Verstappen, G. M.

AU - Pringle, S. A.

AU - Spijkervet, F. K. L.

AU - Kroese, F. G. M.

AU - Vissink, A.

AU - Bootsma, H.

PY - 2020/6

Y1 - 2020/6

U2 - 10.1136/annrheumdis-2020-eular.4439

DO - 10.1136/annrheumdis-2020-eular.4439

M3 - Meeting Abstract

SN - 0003-4967

VL - 79

SP - 102

EP - 102

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

Y2 - 3 June 2020

ER -